Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,087 | -4,806 | -28,943 | -21,513 | -15,079 |
| Depreciation Amortization | 229 | 120 | 513 | 384 | 254 |
| Accounts payable and accrued liabilities | -260 | 439 | -646 | -1,138 | -43 |
| Other Working Capital | 175 | 143 | -760 | -587 | -55 |
| Other Operating Activity | -1,405 | -2,577 | 3,364 | 2,674 | 1,190 |
| Operating Cash Flow | $-14,348 | $-6,680 | $-26,472 | $-20,180 | $-13,733 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -15 | -10 | -10 | -6 |
| Investing Cash Flow | $-24 | $-15 | $-10 | $-10 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,667 | -833 | -278 | 0 | N/A |
| Common Stock Issued | 2,369 | 140 | 24,162 | 15,245 | 15,115 |
| Financing Cash Flow | $702 | $-693 | $23,884 | $15,245 | $15,115 |
| Beginning Cash Position | 34,021 | 34,021 | 36,619 | 36,619 | 36,619 |
| End Cash Position | 20,351 | 26,633 | 34,021 | 31,673 | 37,995 |
| Net Cash Flow | $-13,670 | $-7,388 | $-2,597 | $-4,945 | $1,376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,348 | -6,680 | -26,472 | -20,180 | -13,733 |
| Capital Expenditure | -24 | -15 | -10 | -10 | -6 |
| Free Cash Flow | -14,372 | -6,695 | -26,482 | -20,190 | -13,739 |